|By PR Newswire||
|March 5, 2014 04:00 AM EST||
DUBLIN, March 5, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ghwrtz/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering.
The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way.
Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry.
One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices.
Key Topics Covered:
1. Executive Summary
3. Overview And Market Background
4. Target Drugs For Bolus Injectors
5. Product Profiles
6. Market Size And Forecast
7. Swot Analysis
8. Company Profiles
9. Interview Transcripts
11. Appendix 1: Tables
12. Appendix 2: List Of Companies
- Boehringer Ingelheim
- Calando Pharmaceuticals
- Calibra Medical
- Elcam Medical
- Eli Lilly
- Five Prime Therapeutics
- Future Injection Technologies
- Isis Pharmaceuticals
- Janssen Biotech
- Kyowa Hakko Kirin
- Lincoln Medical Limited
- Nuron Biotech
- OncoGenex Technologies
- PhaseBio Pharmaceuticals
- SteadyMed Therapeutics
- Synageva BioPharma
- TaiMed Biologics
- Takeda Pharmaceuticals
- VBL Therapeutics
- West Pharmaceutical Services
- ZZ Biotech
For more information visit http://www.researchandmarkets.com/research/ghwrtz/bolus_injectors
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Oct. 9, 2015 02:00 AM EDT Reads: 278
Interested in leveraging automation technologies and a cloud architecture to make developers more productive? Learn how PaaS can benefit your organization to help you streamline your application development, allow you to use existing infrastructure and improve operational efficiencies. Begin charting your path to PaaS with OpenShift Enterprise.
Oct. 9, 2015 02:00 AM EDT Reads: 541
Oct. 9, 2015 02:00 AM EDT Reads: 278
Internet of Things (IoT) will be a hybrid ecosystem of diverse devices and sensors collaborating with operational and enterprise systems to create the next big application. In their session at @ThingsExpo, Bramh Gupta, founder and CEO of robomq.io, and Fred Yatzeck, principal architect leading product development at robomq.io, discussed how choosing the right middleware and integration strategy from the get-go will enable IoT solution developers to adapt and grow with the industry, while at th...
Oct. 9, 2015 02:00 AM EDT Reads: 2,163
Oct. 9, 2015 02:00 AM EDT Reads: 204
Today’s connected world is moving from devices towards things, what this means is that by using increasingly low cost sensors embedded in devices we can create many new use cases. These span across use cases in cities, vehicles, home, offices, factories, retail environments, worksites, health, logistics, and health. These use cases rely on ubiquitous connectivity and generate massive amounts of data at scale. These technologies enable new business opportunities, ways to optimize and automate, al...
Oct. 9, 2015 02:00 AM EDT Reads: 160
Data loss happens, even in the cloud. In fact, if your company has adopted a cloud application in the past three years, data loss has probably happened, whether you know it or not. In his session at 17th Cloud Expo, Bryan Forrester, Senior Vice President of Sales at eFolder, will present how common and costly cloud application data loss is and what measures you can take to protect your organization from data loss.
Oct. 9, 2015 02:00 AM EDT Reads: 557
Oct. 9, 2015 02:00 AM EDT Reads: 200
Oct. 9, 2015 02:00 AM EDT Reads: 869
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," explained Peter Dunkley, Technical Director at Acision, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Oct. 9, 2015 01:45 AM EDT Reads: 6,973
Oct. 9, 2015 01:00 AM EDT Reads: 129
Oct. 9, 2015 12:30 AM EDT Reads: 244
Oct. 9, 2015 12:30 AM EDT Reads: 630
Oct. 9, 2015 12:00 AM EDT Reads: 218
Oct. 9, 2015 12:00 AM EDT Reads: 1,127